New Antibody-Drug Conjugate SCR-A008 Shows Powerful Tumor Suppression in Gastric Cancer Models
A novel CDH17-targeted antibody-drug conjugate called SCR-A008 achieved sustained tumor inhibition in gastric cancer PDX models, with a paclitaxel combination ...
